ARCA biopharma, Inc. (ABIO) Financials
ABIO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 37.9 million | 841000 |
| 2023-09-30 | 39.2 million | 1.2 million |
| 2023-06-30 | 41.1 million | 1.8 million |
| 2023-03-31 | 42.1 million | 1.5 million |
ABIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.1 million | 141000 |
| 2023-09-30 | -1.7 million | 154000 |
| 2023-06-30 | -694000 | 187000 |
| 2023-03-31 | -1.6 million | 204000 |
ABIO Net Income
No data available :(
ABIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 37.4 million | - | 204000 |
| 2023-09-30 | 38.5 million | - | 224000 |
| 2023-06-30 | 40.2 million | - | 243000 |
| 2023-03-31 | 40.9 million | - | 262000 |
ABIO Shares Outstanding
ABIO Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 47000 | 1.5 million | - |
| 2023-09-30 | - | 322000 | 1.6 million | - |
| 2023-06-30 | - | 254000 | 1.7 million | - |
| 2023-03-31 | - | 390000 | 1.4 million | - |
ABIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | 23000 |
| 2023-09-30 | - | 30000 |
| 2023-06-30 | - | 29000 |
| 2023-03-31 | - | 29000 |
ABIO
Price: $3.26
52 week price:
Earnings Per Share: -0.37 USD
P/E Ratio: -4.32
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 21900
Ebitda: -14.2 millionMarket Capitalization: 44.8 million